ICU · Rehabilitation
Acute severe community-acquired pneumonia:CAP readmission and recurrence prevention
Also known as CAP readmission prevention · CAP recurrence · Post-discharge complications · CAP prevention strategies · 30-day pneumonia readmission · Post-pneumonia discharge bundle
CAP readmission within 30 days affects roughly 1 in 10 to 1 in 4 patients across published cohorts (8-26%) and is a widely tracked hospital quality metric. Causes: incomplete recovery, complications (empyema, abscess), comorbidity exacerbation (COPD, heart failure), secondary infection, medication non-adherence, premature return to activity. Repeated-CAP readmission runs about 5% within 30 days in a population-based cohort, with CAP-unrelated readmissions roughly three times commoner (higher risk in: elderly, long-term care need, COPD, heart failure, diabetes, CKD, dementia, immunocompromised, smokers, structural lung disease, social isolation, poor functional status, previous CAP hospitalisation, aspiration risk). Prevention strategies: (1) Complete antibiotic course. (2) Smoking cessation. (3) Vaccination (pneumococcal conjugate — PCV20 or PCV21 alone, or PCV15 in series with PPSV23 per ACIP; influenza annual; COVID; RSV in elderly). (4) Treat underlying conditions (COPD optimisation, dental care for aspiration risk, heart-failure and diabetes optimisation). (5) Gradual return to activity. (6) Follow-up (GP within 7 days, CXR 6 weeks). (7) Patient education (warning signs, written action plan). (8) Pulmonary rehabilitation. (9) Address PICS (physical + cognitive impairment increases readmission risk). (10) Structured discharge bundle (medication reconciliation, follow-up appointment scheduled before discharge, vaccination offered, smoking-cessation referral, deterioration action plan).
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- 30-day readmission after CAP runs 8-26% across cohorts — a quality failure worth investigating
- Recurrent CAP (>2 episodes/year) = investigate: immunodeficiency, structural lung disease, aspiration risk, malignancy
- Non-resolving pneumonia at 6 weeks = investigate malignancy/TB/bronchiectasis
- Premature discharge (before meeting clinical stability criteria) = increased readmission risk
- New/worsening dyspnoea, fever or sputum within 7 days of discharge = likely genuine relapse — reassess and admit
- Age and need for long-term care each roughly double the 30-day risk of readmission or death after CAP (HR up to 2.09 and 1.99)
- Untreated dysphagia post-discharge = recurrent aspiration pneumonia within weeks
Meet the patient
A 78-year-old man goes home on day five of a bacteraemic pneumococcal pneumonia, after four days in ICU for type 1 respiratory failure. He has COPD, heart failure, lives alone since his wife died, and his LACE score is 12. Eight days later he is back in the emergency department breathless, with the same fluffy lower-zone shadowing the radiologist calls "recurrent pneumonia".[2][3]
The question that decides whether he bounces a third time is one whole topic hangs on: was he actually stable at discharge, is the comorbidity controlled, is he vaccinated, and is the follow-up booked? Everything below is just the disciplined unpacking of those four.[5]
References21ShowHide
- [1]Niederman MS, Torres A. Severe community-acquired pneumonia Eur Respir Rev, 2022.PMID 36517046
- [2]Chakrabarti B, Lane S, Jenks T, et al. Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia BMJ Open Respir Res, 2021.PMID 33771814
- [3]Toledo D, Soldevila N, Torner N, et al. Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions BMJ Open, 2018.PMID 29602852
- [4]Jang JG, Ahn JH. Reasons and Risk Factors for Readmission Following Hospitalization for Community-acquired Pneumonia in South Korea Tuberc Respir Dis (Seoul), 2020.PMID 32185918
- [5]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America Am J Respir Crit Care Med, 2019.PMID 31573350
- [6]Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults N Engl J Med, 2015.PMID 25785969
- [7]Cillóniz C, Amaro R, Torres A. Pneumococcal vaccination Curr Opin Infect Dis, 2016.PMID 26779776
- [8]Walsh EE, Pérez Marc G, Zareba AM, et al. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults N Engl J Med, 2023.PMID 37018468
- [9]Uyeki TM, Hui DS, Zambon M, et al. Influenza Lancet, 2022.PMID 36030813
- [10]Cecere LM, Williams EC, Sun H, et al. Smoking cessation and the risk of hospitalization for pneumonia Respir Med, 2012.PMID 22541719
- [11]Banda KJ, Chu H, Kang XL, et al. Prevalence of dysphagia and risk of pneumonia and mortality in acute stroke patients: a meta-analysis BMC Geriatr, 2022.PMID 35562660
- [12]Zang K, Chen B, Wang M, et al. The effect of early mobilization in critically ill patients: A meta-analysis Nurs Crit Care, 2020.PMID 31219229
- [13]Deutz NE, Matheson EM, Matarese LE, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: A randomized clinical trial Clin Nutr, 2016.PMID 26797412
- [14]Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis BMJ Open, 2016.PMID 26908524
- [15]Granata D, Kendra M, Chiu SH. A Case Manager-Led Pneumonia Care Bundle in a Subacute Rehabilitation Facility Prof Case Manag, 2023.PMID 36662658
- [16]Kumar Khurana A, Hussain A, Goyal A, et al. Six-Week Hospital-Based Pulmonary Rehabilitation in Covid Pneumonia ICU Survivors: Experience from a Tertiary Care Center in Central India Turk Thorac J, 2022.PMID 35404239
- [17]Reichel F, Tesch F, Berger S, et al. Burden and risk factors for 30-day readmission and mortality after CAP hospitalization: A population-based cohort study Eur J Intern Med, 2025.PMID 40268582
- [18]Donzé J, Aujesky D, Williams D, et al. Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model JAMA Intern Med, 2013.PMID 23529115
- [19]van Walraven C, Dhalla IA, Bell C, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community CMAJ, 2010.PMID 20194559
- [20]Kobayashi M, Leidner AJ, Gierke R, et al. Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged >=50 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024 MMWR Morb Mortal Wkly Rep, 2025.PMID 39773952
- [21]Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD N Engl J Med, 2011.PMID 21864166